APO RESEARCH · REPORT
Developmental and Reproductive Toxicology (DART) Services
Selected research
Industry Research
Developmental and Reproductive Toxicology (DART) Services Industry Research Report 2026
Market perspective
The global Developmental and Reproductive Toxicology (DART) Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Developmental and Reproductive Toxicology (DART) Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Developmental and Reproductive Toxicology (DART) Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Developmental and Reproductive Toxicology (DART) Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Developmental and Reproductive Toxicology (DART) Services include AnaPath Services, Frontage, WuXi AppTec, Creative Animodel, Pharmaron, Labcorp, RCC, Creative Biolabs and IITRI, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Developmental and Reproductive Toxicology (DART) Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Developmental and Reproductive Toxicology (DART) Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Developmental and Reproductive Toxicology (DART) Services Market by Company
AnaPath Services
Frontage
WuXi AppTec
Creative Animodel
Pharmaron
Labcorp
RCC
Creative Biolabs
IITRI
Syngene
JOINN
Inotiv
Accelera
Charles River
Developmental and Reproductive Toxicology (DART) Services Segment by Type
Fertility and Early Embryonic Development (FEED) study
Embryofetal Development (EFD) study
Pre- and Post-natal (PPND) study
Others
Developmental and Reproductive Toxicology (DART) Services Segment by Application
Biotechnology
Academic Research
Others
Developmental and Reproductive Toxicology (DART) Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Developmental and Reproductive Toxicology (DART) Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Developmental and Reproductive Toxicology (DART) Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Developmental and Reproductive Toxicology (DART) Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Developmental and Reproductive Toxicology (DART) Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Fertility and Early Embryonic Development (FEED) study
- Embryofetal Development (EFD) study
- Pre- and Post-natal (PPND) study
- Others
Applications
- Biotechnology
- Academic Research
- Others
Companies covered
- AnaPath Services
- Frontage
- WuXi AppTec
- Creative Animodel
- Pharmaron
- Labcorp
- RCC
- Creative Biolabs
- IITRI
- Syngene
- JOINN
- Inotiv
- Accelera
- Charles River
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Developmental and Reproductive Toxicology (DART) Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Fertility and Early Embryonic Development (FEED) study
- 2.2.3 Embryofetal Development (EFD) study
- 2.2.4 Pre- and Post-natal (PPND) study
- 2.2.5 Others
- 2.3 Developmental and Reproductive Toxicology (DART) Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Biotechnology
- 2.3.3 Academic Research
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Developmental and Reproductive Toxicology (DART) Services Breakdown Data by Type
- 3.1 Global Developmental and Reproductive Toxicology (DART) Services Historic Market Size by Type (2021-2026)
- 3.2 Global Developmental and Reproductive Toxicology (DART) Services Forecasted Market Size by Type (2027-2032)
4 Developmental and Reproductive Toxicology (DART) Services Breakdown Data by Application
- 4.1 Global Developmental and Reproductive Toxicology (DART) Services Historic Market Size by Application (2021-2026)
- 4.2 Global Developmental and Reproductive Toxicology (DART) Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Developmental and Reproductive Toxicology (DART) Services Market Perspective (2021-2032)
- 5.2 Global Developmental and Reproductive Toxicology (DART) Services Growth Trends by Region
- 5.2.1 Global Developmental and Reproductive Toxicology (DART) Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Developmental and Reproductive Toxicology (DART) Services Historic Market Size by Region (2021-2026)
- 5.2.3 Developmental and Reproductive Toxicology (DART) Services Forecasted Market Size by Region (2027-2032)
- 5.3 Developmental and Reproductive Toxicology (DART) Services Market Dynamics
- 5.3.1 Developmental and Reproductive Toxicology (DART) Services Industry Trends
- 5.3.2 Developmental and Reproductive Toxicology (DART) Services Market Drivers
- 5.3.3 Developmental and Reproductive Toxicology (DART) Services Market Challenges
- 5.3.4 Developmental and Reproductive Toxicology (DART) Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Developmental and Reproductive Toxicology (DART) Services Players by Revenue
- 6.1.1 Global Top Developmental and Reproductive Toxicology (DART) Services Players by Revenue (2021-2026)
- 6.1.2 Global Developmental and Reproductive Toxicology (DART) Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Developmental and Reproductive Toxicology (DART) Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Developmental and Reproductive Toxicology (DART) Services Head Office and Area Served
- 6.4 Global Developmental and Reproductive Toxicology (DART) Services Players, Product Type & Application
- 6.5 Global Developmental and Reproductive Toxicology (DART) Services Manufacturers Established Date
- 6.6 Global Developmental and Reproductive Toxicology (DART) Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032)
- 7.2 North America Developmental and Reproductive Toxicology (DART) Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2021-2026)
- 7.4 North America Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032)
- 8.2 Europe Developmental and Reproductive Toxicology (DART) Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2021-2026)
- 8.4 Europe Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032)
- 9.2 Asia-Pacific Developmental and Reproductive Toxicology (DART) Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032)
- 10.2 South America Developmental and Reproductive Toxicology (DART) Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2021-2026)
- 10.4 South America Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032)
- 11.2 Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 AnaPath Services
- 12.1.1 AnaPath Services Company Information
- 12.1.2 AnaPath Services Business Overview
- 12.1.3 AnaPath Services Revenue in Developmental and Reproductive Toxicology (DART) Services Business (2021-2026)
- 12.1.4 AnaPath Services Developmental and Reproductive Toxicology (DART) Services Product Portfolio
- 12.1.5 AnaPath Services Recent Developments
- 12.2 Frontage
- 12.2.1 Frontage Company Information
- 12.2.2 Frontage Business Overview
- 12.2.3 Frontage Revenue in Developmental and Reproductive Toxicology (DART) Services Business (2021-2026)
- 12.2.4 Frontage Developmental and Reproductive Toxicology (DART) Services Product Portfolio
- 12.2.5 Frontage Recent Developments
- 12.3 WuXi AppTec
- 12.3.1 WuXi AppTec Company Information
- 12.3.2 WuXi AppTec Business Overview
- 12.3.3 WuXi AppTec Revenue in Developmental and Reproductive Toxicology (DART) Services Business (2021-2026)
- 12.3.4 WuXi AppTec Developmental and Reproductive Toxicology (DART) Services Product Portfolio
- 12.3.5 WuXi AppTec Recent Developments
- 12.4 Creative Animodel
- 12.4.1 Creative Animodel Company Information
- 12.4.2 Creative Animodel Business Overview
- 12.4.3 Creative Animodel Revenue in Developmental and Reproductive Toxicology (DART) Services Business (2021-2026)
- 12.4.4 Creative Animodel Developmental and Reproductive Toxicology (DART) Services Product Portfolio
- 12.4.5 Creative Animodel Recent Developments
- 12.5 Pharmaron
- 12.5.1 Pharmaron Company Information
- 12.5.2 Pharmaron Business Overview
- 12.5.3 Pharmaron Revenue in Developmental and Reproductive Toxicology (DART) Services Business (2021-2026)
- 12.5.4 Pharmaron Developmental and Reproductive Toxicology (DART) Services Product Portfolio
- 12.5.5 Pharmaron Recent Developments
- 12.6 Labcorp
- 12.6.1 Labcorp Company Information
- 12.6.2 Labcorp Business Overview
- 12.6.3 Labcorp Revenue in Developmental and Reproductive Toxicology (DART) Services Business (2021-2026)
- 12.6.4 Labcorp Developmental and Reproductive Toxicology (DART) Services Product Portfolio
- 12.6.5 Labcorp Recent Developments
- 12.7 RCC
- 12.7.1 RCC Company Information
- 12.7.2 RCC Business Overview
- 12.7.3 RCC Revenue in Developmental and Reproductive Toxicology (DART) Services Business (2021-2026)
- 12.7.4 RCC Developmental and Reproductive Toxicology (DART) Services Product Portfolio
- 12.7.5 RCC Recent Developments
- 12.8 Creative Biolabs
- 12.8.1 Creative Biolabs Company Information
- 12.8.2 Creative Biolabs Business Overview
- 12.8.3 Creative Biolabs Revenue in Developmental and Reproductive Toxicology (DART) Services Business (2021-2026)
- 12.8.4 Creative Biolabs Developmental and Reproductive Toxicology (DART) Services Product Portfolio
- 12.8.5 Creative Biolabs Recent Developments
- 12.9 IITRI
- 12.9.1 IITRI Company Information
- 12.9.2 IITRI Business Overview
- 12.9.3 IITRI Revenue in Developmental and Reproductive Toxicology (DART) Services Business (2021-2026)
- 12.9.4 IITRI Developmental and Reproductive Toxicology (DART) Services Product Portfolio
- 12.9.5 IITRI Recent Developments
- 12.10 Syngene
- 12.10.1 Syngene Company Information
- 12.10.2 Syngene Business Overview
- 12.10.3 Syngene Revenue in Developmental and Reproductive Toxicology (DART) Services Business (2021-2026)
- 12.10.4 Syngene Developmental and Reproductive Toxicology (DART) Services Product Portfolio
- 12.10.5 Syngene Recent Developments
- 12.11 JOINN
- 12.11.1 JOINN Company Information
- 12.11.2 JOINN Business Overview
- 12.11.3 JOINN Revenue in Developmental and Reproductive Toxicology (DART) Services Business (2021-2026)
- 12.11.4 JOINN Developmental and Reproductive Toxicology (DART) Services Product Portfolio
- 12.11.5 JOINN Recent Developments
- 12.12 Inotiv
- 12.12.1 Inotiv Company Information
- 12.12.2 Inotiv Business Overview
- 12.12.3 Inotiv Revenue in Developmental and Reproductive Toxicology (DART) Services Business (2021-2026)
- 12.12.4 Inotiv Developmental and Reproductive Toxicology (DART) Services Product Portfolio
- 12.12.5 Inotiv Recent Developments
- 12.13 Accelera
- 12.13.1 Accelera Company Information
- 12.13.2 Accelera Business Overview
- 12.13.3 Accelera Revenue in Developmental and Reproductive Toxicology (DART) Services Business (2021-2026)
- 12.13.4 Accelera Developmental and Reproductive Toxicology (DART) Services Product Portfolio
- 12.13.5 Accelera Recent Developments
- 12.14 Charles River
- 12.14.1 Charles River Company Information
- 12.14.2 Charles River Business Overview
- 12.14.3 Charles River Revenue in Developmental and Reproductive Toxicology (DART) Services Business (2021-2026)
- 12.14.4 Charles River Developmental and Reproductive Toxicology (DART) Services Product Portfolio
- 12.14.5 Charles River Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst